425: Strive Board Member Reposts Semler Merger Communication

Strive, Inc. board member Pierre Rochard reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Summary

• A communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on November 10, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc.
• It includes a cautionary statement regarding forward-looking statements related to the proposed transaction, its strategic and financial benefits, timing, and integration.
• The statement highlights inherent risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Investors are directed to various SEC filings, including Strive's Form S-4, 10-K, and 8-K, and Semler Scientific's Form 10-K and 10-Q, for additional information.
• Stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus when they become available before making any voting or investment decisions.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure regarding a proposed business combination, primarily focusing on cautionary statements about forward-looking information and associated risks, maintaining a neutral tone.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company, including anticipated cost savings and strategic gains.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to conditions not being met.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all, potentially due to changes in or problems arising from Bitcoin treasury strategies and risks associated with digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws, and regulations and their enforcement could adversely affect the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including successful integration and a positive impact on future financial performance. However, these forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted this communication on X.com on November 10, 2025, in connection with the proposed business combination.

Industry Context

The filing's mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates that the proposed combined entity may be engaging with or exposed to the evolving trend of corporate adoption of digital assets for treasury management, a notable development in certain sectors.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor.

Related Party Transactions

• Information regarding Semler Scientific's transactions with related persons is available in its definitive proxy statement filed with the SEC on July 17, 2025, in connection with its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders: Potential for dilution due to Strive's issuance of additional Class A common stock; will be required to vote on the proposed transaction.
• Customers: Potential for adverse reactions to the announcement or completion of the proposed transaction.
• Employees: Potential for changes to business or employee relationships resulting from the proposed transaction.

Next Steps

• Strive will file a definitive Information Statement/Proxy Statement/Prospectus with the SEC.
• Semler Scientific stockholders will be sent the definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus, and any amendments or supplements, when they become available.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury Strategy, Digital Assets, Corporate Governance